Trial Profile
A Multicenter,Randomized,Open-label,Parallel-group,and Adaptive Design Clinical Study to Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With Major Depressive Disorder
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Nov 2020
Price :
$35
*
At a glance
- Drugs Hypidone Hydrochloride (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Zhejiang Huahai Pharmaceutical
- 30 Dec 2019 Status changed from recruiting to completed.
- 30 Jan 2018 Status changed from not yet recruiting to recruiting.
- 25 Jan 2018 New trial record